$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Nov 28, 2025)
$2.66B
Market Cap
-
P/E Ratio
-1.75
EPS
$90.32
52 Week High
$41.50
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Soleno Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Redwood City, California, dedicated to developing innovative therapies for rare diseases. Leveraging its proprietary drug development platform, Soleno is committed to advancing novel treatments through clinical trials, addressing significant unmet medical needs. The company's focus on pioneering solutions in the rare disease sector positions it as an appealing investment opportunity for institutional investors seeking to engage with the forefront of biopharmaceutical innovation and capitalize on potential market advancements.
LPTX
VHAI
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
BIYA
AAL
TSLA
CIFR
PFE
MARA
WULF
NIO
F
MTSR
IREN
SOFI
VALE
GOOGL
BTBT
ADTX
DVLT
GRAB
DNN
IBRX
RIOT
CAN
WBD
AG
APLD
GOOG
RIG
BAC
AMD
KSS
RR
SMR
WMT
TMC
CDE
PLTR
ITUB
AGNC
KDLY
T
AMC
NVO
MSTR
NFLX
SAND
MSFT
HBAN
LPTX
VHAI
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
BIYA
AAL
TSLA
CIFR
PFE
MARA
WULF
NIO
F
MTSR
IREN
SOFI
VALE
GOOGL
BTBT
ADTX
DVLT
GRAB
DNN
IBRX
RIOT
CAN
WBD
AG
APLD
GOOG
RIG
BAC
AMD
KSS
RR
SMR
WMT
TMC
CDE
PLTR
ITUB
AGNC
KDLY
T
AMC
NVO
MSTR
NFLX
SAND
MSFT
HBAN